Genetic Polymorphisms in the MiR-372 (rs12983273) and LncRNA HULC (rs7763881) Genes and Susceptibility to Hepatitis B Virus (HBV) Infection

Overview

Journal Mol Biol Rep

Specialty Molecular Biology

Date 2021 Oct 22

PMID 34677712

Citations 4

Authors

Samar M Shahen

Sohi Z Elshenawy

Salwa E Mohamed

Robe M Talaat

Affiliations

Soon will be listed here.

Abstract

Background: MicroRNAs (miRNAs) and Long non-coding RNAs (lncRNAs) are two major types of non-coding RNAs (ncRNAs) with regulatory roles. The initiation and progression of numerous diseases have been linked to genetic variation in miRNAs and lncRNAs. Many diseases, including hepatitis infection, are thought to be regulated by miRNA-LncRNA interactions. In this study, Single nucleotide polymorphisms (SNPs) in miR-372 (rs28461391 C/T) and HULC (rs7763881 A/C) were believed to play a role in HBV infection risk.

Methods And Results: Using the Polymerase chain reaction sequence-specific primer technique (PCR-SSP), 100 HBV patients and 100 healthy controls were genotyped for SNPs rs28461391 in miR-372 and rs7763881 in HULC. There was no significant difference in miR-372 rs12983273 genotype distribution between controls and HBV patients, according to our findings. On the other hand, there was a significant increase in HULC rs7763881 CC genotype (P < 0.05) coincides with a significant decrease in AC genotype distribution (P < 0.05) in HBV patients as compared to controls. Our results showed that the AA genotype is protective for HBV infection (OR 0.3; CI 0.13-9.07) while the CC genotype is associated with an increased risk of HBV infection (OR 3.43; CI 1.3-9.07).

Conclusions: Our results suggest that HULC rs7763881 A/C might be a biomarker for HBV susceptibility. Larger sample studies are needed to confirm our preliminary data. To the best of our knowledge, the present study was the first to investigate the relevance of miR-372 (rs28461391 C/T) and HULC (rs7763881 A/C) gene polymorphisms to the risk of HBV infection in the Egyptian population.

Citing Articles

Interleukin-16 genetic polymorphisms in Guangxi Chinese with hepatitis B virus-related liver cirrhosis.

Zhang X, Tang W, Qin X, Li S, Liang D Mol Biol Rep. 2023; 50(6):5247-5254.

PMID: 37138138 DOI: 10.1007/s11033-023-08450-0.

MicroRNAs: Small Molecules with Significant Functions, Particularly in the Context of Viral Hepatitis B and C Infection.

Megahed F, Tabll A, Atta S, Ragheb A, Smolic R, Petrovic A Medicina (Kaunas). 2023; 59(1).

PMID: 36676797 PMC: 9862007. DOI: 10.3390/medicina59010173.

Long non-coding RNA WAC antisense RNA 1 mediates hepatitis B virus replication <em>in vitro</em> by reinforcing miR-192-5p/ATG7-induced autophagy.

Cao M, Yuan D, Jiang H, Zhou G, Chen C, Han G Eur J Histochem. 2022; 66(3).

PMID: 36053263 PMC: 9471915. DOI: 10.4081/ejh.2022.3438.

Long noncoding RNAs in hepatitis B virus replication and oncogenesis.

Li H, Yang C, Lo S World J Gastroenterol. 2022; 28(25):2823-2842.

PMID: 35978877 PMC: 9280728. DOI: 10.3748/wjg.v28.i25.2823.

References

Bandopadhyay M, Bharadwaj M . Exosomal miRNAs in hepatitis B virus related liver disease: a new hope for biomarker. Gut Pathog. 2020; 12:23. PMC: 7183117. DOI: 10.1186/s13099-020-00353-w. View

Kashi K, Henderson L, Bonetti A, Carninci P . Discovery and functional analysis of lncRNAs: Methodologies to investigate an uncharacterized transcriptome. Biochim Biophys Acta. 2015; 1859(1):3-15. DOI: 10.1016/j.bbagrm.2015.10.010. View

Panni S, Lovering R, Porras P, Orchard S . Non-coding RNA regulatory networks. Biochim Biophys Acta Gene Regul Mech. 2019; 1863(6):194417. DOI: 10.1016/j.bbagrm.2019.194417. View

Motawi T, El-Maraghy S, Sabry D, Mehana N . The expression of long non coding RNA genes is associated with expression with polymorphisms of HULC rs7763881 and MALAT1 rs619586 in hepatocellular carcinoma and HBV Egyptian patients. J Cell Biochem. 2019; 120(9):14645-14656. DOI: 10.1002/jcb.28726. View

Dai X, Kaushik A, Zhang J . The Emerging Role of Major Regulatory RNAs in Cancer Control. Front Oncol. 2019; 9:920. PMC: 6771296. DOI: 10.3389/fonc.2019.00920. View

Sarkar N, Chakravarty R . Hepatitis B Virus Infection, MicroRNAs and Liver Disease. Int J Mol Sci. 2015; 16(8):17746-62. PMC: 4581219. DOI: 10.3390/ijms160817746. View

Wang L, Cho K, Li Y, Tao G, Xie Z, Guo B . Long Noncoding RNA (lncRNA)-Mediated Competing Endogenous RNA Networks Provide Novel Potential Biomarkers and Therapeutic Targets for Colorectal Cancer. Int J Mol Sci. 2019; 20(22). PMC: 6888455. DOI: 10.3390/ijms20225758. View

Elbahrawy A, Ibrahim M, Eliwa A, Alboraie M, Madian A, Aly H . Current situation of viral hepatitis in Egypt. Microbiol Immunol. 2021; 65(9):352-372. DOI: 10.1111/1348-0421.12916. View

Kwak M, Lee D, Cho Y, Cho E, Lee J, Yu S . Association of polymorphism in pri-microRNAs-371-372-373 with the occurrence of hepatocellular carcinoma in hepatitis B virus infected patients. PLoS One. 2012; 7(7):e41983. PMC: 3407047. DOI: 10.1371/journal.pone.0041983. View

10.

Morishita A, Oura K, Tadokoro T, Fujita K, Tani J, Masaki T . MicroRNA Interference in Hepatic Host-Pathogen Interactions. Int J Mol Sci. 2021; 22(7). PMC: 8036276. DOI: 10.3390/ijms22073554. View

11.

Adetunji S, Ajite A, Adetunji B, Olaniran O, Donbraye E . Hepatitis B virus infection among Nigerian pediatric population. J Immunoassay Immunochem. 2020; 42(2):121-128. DOI: 10.1080/15321819.2020.1833918. View

12.

Cao S, Zheng H, Sun B, Wang Z, Liu T, Guo D . Long non-coding RNA highly up-regulated in liver cancer promotes exosome secretion. World J Gastroenterol. 2019; 25(35):5283-5299. PMC: 6761235. DOI: 10.3748/wjg.v25.i35.5283. View

13.

Ratti M, Lampis A, Ghidini M, Salati M, Mirchev M, Valeri N . MicroRNAs (miRNAs) and Long Non-Coding RNAs (lncRNAs) as New Tools for Cancer Therapy: First Steps from Bench to Bedside. Target Oncol. 2020; 15(3):261-278. PMC: 7283209. DOI: 10.1007/s11523-020-00717-x. View

14.

Sanchez Calle A, Kawamura Y, Yamamoto Y, Takeshita F, Ochiya T . Emerging roles of long non-coding RNA in cancer. Cancer Sci. 2018; 109(7):2093-2100. PMC: 6029823. DOI: 10.1111/cas.13642. View

15.

Diamantopoulos M, Tsiakanikas P, Scorilas A . Non-coding RNAs: the riddle of the transcriptome and their perspectives in cancer. Ann Transl Med. 2018; 6(12):241. PMC: 6046292. DOI: 10.21037/atm.2018.06.10. View

16.

Shah V, Shah J . Recent trends in targeting miRNAs for cancer therapy. J Pharm Pharmacol. 2020; 72(12):1732-1749. DOI: 10.1111/jphp.13351. View

17.

Kitab B, Alj H, Ezzikouri S, Benjelloun S . MicroRNAs as Important Players in Host-hepatitis B Virus Interactions. J Clin Transl Hepatol. 2015; 3(2):149-61. PMC: 4548348. DOI: 10.14218/JCTH.2015.00002. View

18.

Zhu Y, Zhang X, Qi L, Cai Y, Yang P, Xuan G . HULC long noncoding RNA silencing suppresses angiogenesis by regulating ESM-1 via the PI3K/Akt/mTOR signaling pathway in human gliomas. Oncotarget. 2016; 7(12):14429-40. PMC: 4924726. DOI: 10.18632/oncotarget.7418. View

19.

Su W, Tang J, Wang Y, Sun S, Shen Y, Yang H . Long non-coding RNA highly up-regulated in liver cancer promotes epithelial-to-mesenchymal transition process in oral squamous cell carcinoma. J Cell Mol Med. 2019; 23(4):2645-2655. PMC: 6433680. DOI: 10.1111/jcmm.14160. View

20.

Martin P, Nguyen M, Dieterich D, Lau D, Janssen H, Peters M . Treatment Algorithm for Managing Chronic Hepatitis B Virus Infection in the United States: 2021 Update. Clin Gastroenterol Hepatol. 2021; 20(8):1766-1775. DOI: 10.1016/j.cgh.2021.07.036. View